A detailed history of Cary Street Partners Investment Advisory LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 64,311 shares of ABT stock, worth $7.38 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
64,311
Previous 65,944 2.48%
Holding current value
$7.38 Million
Previous $6.85 Million 7.01%
% of portfolio
0.28%
Previous 0.28%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$100.07 - $118.13 $163,414 - $192,906
-1,633 Reduced 2.48%
64,311 $7.33 Million
Q2 2024

Jul 22, 2024

BUY
$100.73 - $112.44 $823,870 - $919,646
8,179 Added 14.16%
65,944 $6.85 Million
Q1 2024

Apr 30, 2024

BUY
$109.52 - $120.96 $549,899 - $607,340
5,021 Added 9.52%
57,765 $6.57 Million
Q4 2023

Feb 07, 2024

BUY
$90.19 - $110.4 $3.37 Million - $4.13 Million
37,384 Added 243.39%
52,744 $5.81 Million
Q4 2023

Feb 05, 2024

SELL
$90.19 - $110.4 $3.21 Million - $3.93 Million
-35,555 Reduced 69.83%
15,360 $1.69 Million
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $1.5 Million - $1.8 Million
15,732 Added 44.71%
50,915 $4.93 Million
Q2 2023

Aug 10, 2023

BUY
$100.78 - $112.29 $424,888 - $473,414
4,216 Added 13.61%
35,183 $3.84 Million
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $2.86 Million - $3.37 Million
-29,556 Reduced 48.83%
30,967 $3.14 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $3.04 Million - $3.57 Million
-32,005 Reduced 34.59%
60,523 $6.65 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $625,359 - $724,049
6,463 Added 7.51%
92,528 $8.95 Million
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $7.56 Million - $9.14 Million
74,052 Added 616.43%
86,065 $9.35 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $381,624 - $465,366
-3,347 Reduced 21.79%
12,013 $1.42 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $381,595 - $467,242
3,303 Added 27.39%
15,360 $2.16 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $108,493 - $120,025
-930 Reduced 7.16%
12,057 $1.42 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $750,897 - $883,913
7,098 Added 120.53%
12,987 $1.51 Million
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $1.02 Million - $1.21 Million
-9,406 Reduced 61.5%
5,889 $706,000
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $1.58 Million - $1.73 Million
-15,094 Reduced 49.67%
15,295 $1.68 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $2.52 Million - $3.06 Million
27,491 Added 948.62%
30,389 $3.31 Million
Q2 2020

Aug 05, 2020

BUY
$76.57 - $98.0 $221,899 - $284,004
2,898 New
2,898 $264,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cary Street Partners Investment Advisory LLC Portfolio

Follow Cary Street Partners Investment Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.